共 231 条
[1]
Vincent JL(2009)International study of the prevalence and outcomes of infection in intensive care units JAMA 302 2323-2329
[2]
Rello J(2017)Effect of a multifaceted educational intervention for anti-infectious measures on sepsis mortality: a cluster randomized trial Intensive Care Med 43 1602-1612
[3]
Marshall J(2002)Clinical importance of delays in the initiation of appropriate antibiotic treatment for ventilator-associated pneumonia Chest. 122 262-268
[4]
Silva E(2005)Antimicrobial therapy in critically ill patients: a review of pathophysiological conditions responsible for altered disposition and pharmacokinetic variability Clin Pharmacokinet 44 1009-1034
[5]
Anzueto A(2014)Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions Lancet Infect Dis 14 498-509
[6]
Martin CD(2019)Heterogeneity in sepsis: new biological evidence with clinical applications Crit Care. 23 80-96
[7]
Bloos F(1995)Interrelationship between pharmacokinetics and pharmacodynamics in determining dosage regimens for broad-spectrum cephalosporins Diagn Microbiol Infect Dis 22 89-12
[8]
Rüddel H(1998)Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men Clin Infect Dis 26 1-22
[9]
Thomas-Rüddel D(1998)The pharmacodynamics of β-lactams Clin Infect Dis 27 10-351
[10]
Schwarzkopf D(2008)Evaluation of area under the inhibitory curve (AUIC) and time above the minimum inhibitory concentration (T>MIC) as predictors of outcome for cefepime and ceftazidime in serious bacterial infections Int J Antimicrob Agents 31 345-153